OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
Completed
Japan Heart Foundation
Phase 4
2005-08-01
The purpose of this study is to investigate whether high-dose angiotensin II receptor blocker
(ARB) monotherapy or combination therapy with ARB and calcium channel blockers is more
effective in reducing the incidence of cardiovascular events in Japanese elderly high-risk
hypertensive patients not adequately controlled by standard dose ARB alone.
OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
Completed
OSCAR Study
Phase 4
2005-08-01
The purpose of this study is to investigate whether high-dose angiotensin II receptor blocker
(ARB) monotherapy or combination therapy with ARB and calcium channel blockers is more
effective in reducing the incidence of cardiovascular events in Japanese elderly high-risk
hypertensive patients not adequately controlled by standard dose ARB alone.
Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
Completed
Pfizer
Phase 3
2005-09-01
Efficacy, tolerability and safety of olmesartan alone or in combination with
hydrochlorothiazide in the treatment of mild to moderate essential hypertension
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
